Literature DB >> 3537148

Discrepancy between the localization of in vivo bound immunoglobulins in the skin and in vitro binding sites of circulating anti-BMZ antibodies in bullous pemphigoid: immunoelectron microscopic studies.

Y Horiguchi, S Imamura.   

Abstract

The immunoelectron microscopic reaction products showing in vivo bound immunoglobulins or complement in the basement membrane zone (BMZ) of the lesional skin of 12 patients with bullous pemphigoid (BP) were homogeneously distributed in the lamina lucida in 3 cases, just beneath the basilar surface of the basal cells in 5 cases, and were associated with the basal lamina in 4 cases. No reaction products could be found beneath the melanocytes in any of the first 2 groups; however, positive reaction products were found on the basal lamina beneath some melanocytes, and were associated with the detached basal lamina in the dermis in the latter 4 cases. In vitro binding sites of circulating anti-BMZ antibodies in the sera from 7 patients with BP indicated that the antibodies reacted with the basilar surface of the hemidesmosomes, with a weak reaction on the basal lamina in 5 cases and with no reaction in 2 cases. No positive findings were obtained beneath the melanocytes or on the basal lamina under the melanocytes. The discrepancy between the antigenic sites and the localization of immune deposits in BP is assumed to be due to the renewal of the hemidesmosomes and constant clearance of immune deposits in vivo. The in vivo bound immunoglobulins and complement seen in the BP skin are the result of their accumulation in the lamina lucida or in association with the basal lamina.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3537148     DOI: 10.1111/1523-1747.ep12456694

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  6 in total

Review 1.  Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases.

Authors:  J R Stanley
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

2.  1-2B7B: monoclonal antibody reacting to the 120 kDa polypeptide component of human epidermal hemidesmosomes.

Authors:  X M Zhang; Y Horiguchi; M Ueda; T Yoshiki; S Imamura
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

3.  Demonstration of intra- and extracellular localization of bullous pemphigoid antigen using cryofixation and freeze substitution for postembedding immunoelectron microscopy.

Authors:  H Shimizu; J N McDonald; A R Kennedy; R A Eady
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

4.  Synthesis of epidermolysis bullosa acquisita antigen by simian virus 40-transformed human keratinocytes.

Authors:  N Okada; S Miyagawa; Y Horiguchi; Y Kitano; K Yoshikawa; K Sakamoto; M L Steinberg
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

5.  Human autoantibodies against the 230-kD bullous pemphigoid antigen (BPAG1) bind only to the intracellular domain of the hemidesmosome, whereas those against the 180-kD bullous pemphigoid antigen (BPAG2) bind along the plasma membrane of the hemidesmosome in normal human and swine skin.

Authors:  A Ishiko; H Shimizu; A Kikuchi; T Ebihara; T Hashimoto; T Nishikawa
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

Review 6.  Recent advances on the 180-kDa epidermal antigen in autoimmune subepidermal bullous skin diseases.

Authors:  P Bernard
Journal:  Springer Semin Immunopathol       Date:  1992
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.